PrEParing to End the Epidemic

Target Audience

The educational design of this enduring activity addresses the needs of primary care nurse practitioners (NPs) and physician assistants (PAs) to support their competence in HIV prevention, including the provision of preexposure prophylaxis (PrEP), in the primary care setting.

Program Description

This educational program will focus on how to identify and engage with patients at high risk for HIV infection, use nonjudgmental communication skills to remove the stigma associated with HIV, and foster meaningful discussions about sexual health and behavior. It will also provide practical clinical information on implementing PrEP services in primary care practice, including the safety and efficacy of oral and long-acting injectable PrEP agents, initiating and monitoring patients on PrEP, and using shared decision-making to address patient preferences and priorities for HIV prevention.

Educational Objectives

After completing this activity, the participant should be better able to:

• Incorporate effective sexual behavior and health discussions into routine primary care to identify and engage patients who are at high risk for acquiring HIV
• Describe the mechanisms, efficacy, safety, and indications of available and emerging PrEP agents
• Develop evidence-based, individualized approaches to PrEP selection that incorporate patient-specific factors and preferences
• Implement PrEP in the primary care setting with optimal strategies for treatment initiation, monitoring, and follow-up care

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and Integritas Communications. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Physician Continuing Medical Education

PIM designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.

Disclosure of Conflicts of Interest

PIM requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.

PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Shauna Applin, A-NP, AAHIVS  - Consulting Fee: Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc.; Contracted Research: Gilead Sciences, Inc. (PI); Speakers Bureau: Gilead Sciences, Inc., Merck & Co., Inc. 

The PIM and Integritas Communications planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Instructions to Receive Credit

In order to receive credit, participants must complete the following:

1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
2. Complete the Preactivity Questions.
3. Review the activity content.
4. Achieve a grade of at least 70% on the Postactivity Test Questions and complete the Evaluation.

CME Questions – PIM Contact Information

For information about the accreditation of this program, please contact PIM via email at inquiries@pimed.com or at http://www.pimed.com/.

Integritas Contact Information

For all other questions regarding this activity, please contact Integritas via email at info@exchangecme.com.